BridgeMD
New treatment option for Esophageal Cancer
Official title Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
ClinicalTrials.gov ID: NCT06346080
What this study is testing
- What it's testing
- The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: Which diagnostic modality is preferred by patients and the general population?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance)
- Access to computer or smartphone
- Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)
You likely can't join if
- Individuals less than 18yo and more than 75yo
- Incarcerated individuals
The study team makes the final eligibility decision.
Where it's taking place
- Leuven, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leuven, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.